184 related articles for article (PubMed ID: 11894443)
1. Type 2 diabetes management: a comprehensive clinical review of oral medications.
Quillen DM; Kuritzky L
Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic management of diabetes mellitus.
Mozersky RP
J Am Osteopath Assoc; 1999 Dec; 99(12 Suppl):S15-9. PubMed ID: 10659525
[TBL] [Abstract][Full Text] [Related]
3. The use of insulin secretagogues in the treatment of type 2 diabetes.
Luna B; Hughes AT; Feinglos MN
Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467
[TBL] [Abstract][Full Text] [Related]
4. New drugs for diabetes.
Tack CJ; Smits P
Neth J Med; 1999 Nov; 55(5):209-11. PubMed ID: 10593129
[No Abstract] [Full Text] [Related]
5. Diabetes mellitus. Medication update.
Slagle M
South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
[No Abstract] [Full Text] [Related]
6. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
7. Combination therapy in type 2 diabetes: the role of repaglinide.
Moses R
J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
[No Abstract] [Full Text] [Related]
8. Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
Boccuzzi SJ; Wogen J; Fox J; Sung JC; Shah AB; Kim J
Diabetes Care; 2001 Aug; 24(8):1411-5. PubMed ID: 11473078
[TBL] [Abstract][Full Text] [Related]
9. Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Inzucchi SE
JAMA; 2002 Jan; 287(3):360-72. PubMed ID: 11790216
[TBL] [Abstract][Full Text] [Related]
10. Repaglinide in combination therapy.
Moses R
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Kitaoka H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
[No Abstract] [Full Text] [Related]
12. Seeking sweet relief for diabetes.
Dove A
Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
[No Abstract] [Full Text] [Related]
13. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
14. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
15. Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
He S; Qian X; Chen Y; Shen X; Zhang B; Chen X; Xu X; Li G
J Diabetes Res; 2021; 2021():5534387. PubMed ID: 34222493
[TBL] [Abstract][Full Text] [Related]
16. Oral agents in the management of type 2 diabetes mellitus.
Luna B; Feinglos MN
Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
[TBL] [Abstract][Full Text] [Related]
17. [Antidiabetic Drugs and the Kidney].
Candido R
G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960013
[No Abstract] [Full Text] [Related]
18. New directions in type 2 diabetes mellitus: an update of current oral antidiabetic therapy.
Brown DL; Brillon D
J Natl Med Assoc; 1999 Jul; 91(7):389-95. PubMed ID: 10643211
[TBL] [Abstract][Full Text] [Related]
19. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
Bloomgarden ZT
Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
[No Abstract] [Full Text] [Related]
20. Oral combination therapy in primary care.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
